Molecular Testing Is a Valuable Adjunct for Distinguishing Second Primary Tumors of Lung From Intrapulmonary and Extrapulmonary Metastases
Lists
Only you see this
Abstract
Background: Multiple lung tumor nodules may be the result of synchronous second primary tumors (SPTs) or metastasis. Patients with SPTs have better survival and may require different therapy than those with metastatic disease. The distinction between these entities is typically made on histology alone. However, the distinction is not always clear as SPTs may have similar histological appearances and metastases may differ in appearance from their tumors of origin. Molecular studies can play a pivotal role in distinguishing SPT from metastasis. Methods: We present a series of cases in which molecular studies were used to determine whether multiple tumor nodules were SPTs or metastases with significant consequences for treatment, follow-up, and outcome. Results: Case 1: A 61year-old man presents with two lung lesions, one in the right upper lobe and the other in the left upper lobe. Both tumors are morphologically papillary predominant adenocarcinoma. PCR studies demonstrated a KRAS p.G12C mutation in both lesions, and thus the patient was determined to most likely have stage IV disease, not an SPT. Case 2: A 67-year-old woman presents with two right upper lobe lung lesions. Both tumors are morphologically lepidic predominant adenocarcinoma. Next generation sequencing demonstrated a KRAS p.G12C mutation in one lesion and a TP53 p.A159P mutation in the other lesion. The patient was determined to most likely have two stage 1B lesions. Case 3: A 59-year-old woman presents with a buccal lesion and is later found to have a left lower lobe lung mass. The lung mass is morphologically adenosquamous carcinoma while the buccal lesion is squamous cell carcinoma. EGFR mutational analysis of both lesions demonstrated EGFR exon 19 deletions. The patient was determined to have stage IV lung cancer. Conclusion: Molecular methods can be useful as adjunct tests for distinguishing SPT from metastases.
BibTeX
@inproceedings{vanderbilt2015molecular,
author = {Chad Vanderbilt and Daniel T. Merrick and Wilbur A. Franklin and Dara L. Aisner},
title = {{Molecular Testing Is a Valuable Adjunct for Distinguishing Second Primary Tumors of Lung From Intrapulmonary and Extrapulmonary Metastases}},
booktitle = {American},
year = {2015},
doi = {10.1093/ajcp/144.suppl2.244},
}Loading related content...